Perspective Therapeutics, Inc. (CATX)
(Delayed Data from AMEX)
$1.50 USD
-0.01 (-0.66%)
Updated May 24, 2024 04:00 PM ET
After-Market: $1.49 -0.01 (-0.67%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CATX 1.50 -0.01(-0.66%)
Will CATX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CATX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CATX
PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
Earnings Preview: Perspective Therapeutics (CATX) Q4 Earnings Expected to Decline
CATX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Akero Therapeutics (AKRO) Stock Outpacing Its Medical Peers This Year?
Perspective Therapeutics (CATX) Reports Q2 Loss, Lags Revenue Estimates
Onconova Therapeutics, Inc. (ONTX) Reports Q1 Loss, Misses Revenue Estimates
Other News for CATX
Buy Rating Affirmed for Perspective Therapeutics Amid Promising Competitor Data and Treatment Innovations
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Perspective Therapeutics prices its $80M offering of stock, warrants
Perspective Therapeutics files automatic mixed securities shelf
Perspective Therapeutics files automatic mixed securities shelf